Medicine & Life Sciences
Venous Thromboembolism
100%
Multiple Myeloma
68%
Veterans
52%
Thrombosis
30%
Hematology
30%
Lymphoma, Large B-Cell, Diffuse
27%
Anticoagulants
27%
Hemorrhage
22%
Guidelines
21%
Survival
19%
Mortality
17%
Critical Illness
14%
Coronavirus
14%
Confidence Intervals
14%
Hemostasis
13%
Hematologic Neoplasms
12%
Cohort Studies
12%
Neoplasms
12%
Retrospective Studies
12%
Therapeutics
12%
Warfarin
12%
Drug Therapy
11%
Hodgkin Disease
11%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
11%
Pancreatic Neoplasms
10%
Sarcopenia
10%
apixaban
9%
United States Department of Veterans Affairs
9%
Rivaroxaban
9%
abiraterone
8%
Patient Advocacy
8%
MDV 3100
8%
Veterans Health
8%
International Classification of Diseases
8%
Monoclonal Gammopathy of Undetermined Significance
8%
Pamidronate
7%
Obesity
7%
Population
7%
Second Primary Neoplasms
7%
Incidence
7%
Zoledronic Acid
7%
Conflict of Interest
7%
Fibrinolytic Agents
6%
International Normalized Ratio
6%
Immunomodulation
6%
Frailty
6%
Anthracyclines
6%
Bleomycin
6%
Registries
6%
Kidney Neoplasms
6%